<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Site-Server v@build.version@ (http://www.squarespace.com) on Thu, 25 Dec 2025 04:54:38 GMT
--><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://www.rssboard.org/media-rss" version="2.0"><channel><title>A.I. Case Studies (Growth) - Health Business Group</title><link>https://www.healthbusinessgroup.com/ai-case-studies-growth/</link><lastBuildDate>Sun, 14 Dec 2025 14:14:56 +0000</lastBuildDate><language>en-US</language><generator>Site-Server v@build.version@ (http://www.squarespace.com)</generator><description><![CDATA[]]></description><item><title>Pivoting to Clinical Trials: Turning Pandemic Experience into a Growth Engine</title><dc:creator>Li Wang</dc:creator><pubDate>Sun, 14 Dec 2025 14:13:19 +0000</pubDate><link>https://www.healthbusinessgroup.com/ai-case-studies-growth/pivoting-to-clinical-trials-turning-pandemic-experience-into-a-growth-engine</link><guid isPermaLink="false">6238b65ed9ed4068c58aff9b:693ec51b74ef1043669c1bfc:693ec5f195535847b9ad209a</guid><description><![CDATA[When COVID-19 shut down workplaces, the client’s mobile vision-testing 
business evaporated overnight. They successfully repurposed their mobile 
centers to support pharmaceutical trials but were uncertain whether to 
build a long-term clinical-trials business once normal operations resumed.]]></description><content:encoded><![CDATA[<p class="">Client Type: Mobile healthcare services company diversifying into life sciences<br><br>Challenge:<br>When COVID-19 shut down workplaces, the client’s mobile vision-testing business evaporated overnight. They successfully repurposed their mobile centers to support pharmaceutical trials but were uncertain whether to build a long-term clinical-trials business once normal operations resumed.<br><br>Approach:<br>Health Business Group analyzed the decentralized clinical trial market in ophthalmology and beyond, mapped demand drivers ,&nbsp; and benchmarked the client’s capabilities and cost position against traditional sites. We interviewed sponsors, experts, and potential partners to test adoption appetite and investment logic.<br><br>Impact:<br>HBG delivered a data-driven business plan and interactive ROI tool to help quantify value for sponsors. The work aligned the board and management around a clear strategy and investment roadmap for long-term trial participation.<br><br>Why It Matters:<br>Crisis pivots can reveal enduring opportunities. HBG helps healthcare innovators decide which to scale, and which to sunset.</p>]]></content:encoded></item><item><title>Interoperability as Opportunity: Repositioning for Accelerated Growth</title><dc:creator>Li Wang</dc:creator><pubDate>Sun, 14 Dec 2025 14:12:53 +0000</pubDate><link>https://www.healthbusinessgroup.com/ai-case-studies-growth/interoperability-as-opportunity-repositioning-for-accelerated-growth</link><guid isPermaLink="false">6238b65ed9ed4068c58aff9b:693ec51b74ef1043669c1bfc:693ec5d729070e32a071d186</guid><description><![CDATA[New interoperability rules threatened to erode demand for the client’s core 
hospital indexing product. Leadership needed to gauge how much risk the 
regulation posed and to identify growth paths beyond hospitals.]]></description><content:encoded><![CDATA[<p class="">Client Type: PE-backed health-data software company<br><br>Challenge:<br>New interoperability rules threatened to erode demand for the client’s core hospital indexing product. Leadership needed to gauge how much risk the regulation posed and to identify growth paths beyond hospitals.<br><br>Approach:<br>HBG partnered with management to assess capabilities, gaps, and the product roadmap. We synthesized secondary market data and conducted 50+ interviews with payers, life-sciences firms, hospital executives, and potential partners to size new opportunities and test value propositions. Collaboration with an investment banker added M&amp;A options for inorganic growth.<br><br>Impact:<br>The project reframed interoperability from threat to strength, positioning the company as an interoperability solutions provider. We quantified downside protection, identified a new adjacent market with synergy to the core business, and established an M&amp;A filter for strategic fit.<br><br>Why It Matters:<br>When regulation changes the rules, strategy can turn vulnerability into advantage. HBG equips health-IT companies to pivot before markets do.</p><p class="">Thumbnail Summary: Facing new interoperability rules, a PE-backed data firm turned to HBG to assess risks, find adjacent growth areas, and reposition as an interoperability solutions provider.</p><p class="">SEO Meta Description: HBG guided a PE-backed data firm to turn interoperability rules into a strategic growth opportunity.</p>]]></content:encoded></item><item><title>Retail Embraces Digital Health: Creating an Integrated Consumer Platform</title><dc:creator>Li Wang</dc:creator><pubDate>Sun, 14 Dec 2025 14:12:21 +0000</pubDate><link>https://www.healthbusinessgroup.com/ai-case-studies-growth/retail-embraces-digital-health-creating-an-integrated-consumer-platform</link><guid isPermaLink="false">6238b65ed9ed4068c58aff9b:693ec51b74ef1043669c1bfc:693ec5af670f423dc00abc1c</guid><description><![CDATA[The client planned to build in-store health clinics but lacked a digital 
bridge to unify customer health engagement. The innovation group sought 
guidance on how to design and prioritize digital offerings that 
complemented its physical assets.]]></description><content:encoded><![CDATA[<p class="">Client Type: Fortune-100 retailer entering healthcare<br><br>Challenge:<br>The client planned to build in-store health clinics but lacked a digital bridge to unify customer health engagement. The innovation group sought guidance on how to design and prioritize digital offerings that complemented its physical assets.<br><br>Approach:<br>Drawing on deep digital-health expertise, HBG evaluated ecosystem trends, competitive moves by tech and retail entrants, and the specific needs of the client’s demographic base. We combined extensive secondary research with interviews, demos, and conference intelligence to stress-test hypotheses and design new solutions.<br><br>Impact:<br>HBG developed three novel digital-health concepts, complete with interactive prototypes for board review. The analysis persuaded leadership to abandon its “umbrella app” concept in favor of a more viable partner-integrated platform, accelerating time to market and alignment with core strengths.<br><br>Why It Matters:<br>As retail converges with healthcare, success depends on understanding consumer behavior and system complexity. HBG helps large brands find the intersection.</p><p class="">Thumbnail Summary: HBG helped a major retailer entering healthcare design a digital strategy to complement its in-store clinics, creating integrated consumer offerings and accelerating time to market.</p><p class="">SEO Meta Description: HBG supported a national retailer in developing an integrated digital health strategy and accelerating market entry.</p>]]></content:encoded></item><item><title>Consumer-Pay RPM: Expanding Beyond the Physician Channel</title><dc:creator>Li Wang</dc:creator><pubDate>Sun, 14 Dec 2025 14:11:56 +0000</pubDate><link>https://www.healthbusinessgroup.com/ai-case-studies-growth/consumer-pay-rpm-expanding-beyond-the-physician-channel</link><guid isPermaLink="false">6238b65ed9ed4068c58aff9b:693ec51b74ef1043669c1bfc:693ec5953131d0153005db77</guid><description><![CDATA[The client’s physician-office sales model constrained growth. They wanted 
to test whether a direct-to-consumer offering could accelerate adoption and 
feed physician demand.]]></description><content:encoded><![CDATA[<p class="">Client Type: Remote patient monitoring (RPM) company<br><br>Challenge:<br>The client’s physician-office sales model constrained growth. They wanted to test whether a direct-to-consumer offering could accelerate adoption and feed physician demand.<br><br>Approach:<br>Leveraging decades of RPM market knowledge, HBG segmented consumer demand, benchmarked competitors, and analyzed regulatory and reimbursement implications. We developed and tested solution bundles with consumers, identified pricing thresholds, and defined transition paths from self-pay to physician reimbursement.<br><br>Impact:<br>The project validated the consumer-pay opportunity and provided a robust go-to-market plan. Within months, the client launched a new offering aligned with consumer demand and provider economics.<br><br>Why It Matters:<br>Even in B2B healthcare, patient pull can drive adoption. HBG helps digital-health companies design offerings that engage consumers and clinicians.</p><p class="">Thumbnail Summary: HBG guided an RPM company in testing and launching a direct-to-consumer model that expanded market reach and strengthened its physician-channel adoption.</p><p class="">SEO Meta Description: HBG enabled an RPM company to expand growth through a consumer-pay go-to-market strategy.</p>]]></content:encoded></item><item><title>Strengthening Hospital Cybersecurity: From Crisis Response to Collective Resilience</title><dc:creator>Li Wang</dc:creator><pubDate>Sun, 14 Dec 2025 14:11:31 +0000</pubDate><link>https://www.healthbusinessgroup.com/ai-case-studies-growth/strengthening-hospital-cybersecurity-from-crisis-response-to-collective-resilience</link><guid isPermaLink="false">6238b65ed9ed4068c58aff9b:693ec51b74ef1043669c1bfc:693ec58170cb3c6911accf59</guid><description><![CDATA[Ransomware attacks had driven up insurance premiums and threatened coverage 
for member hospitals. The association needed a plan to protect members and 
restore insurer confidence.]]></description><content:encoded><![CDATA[<p class="">Client Type: Statewide hospital association<br><br>Challenge:<br>Ransomware attacks had driven up insurance premiums and threatened coverage for member hospitals. The association needed a plan to protect members and restore insurer confidence.<br><br>Approach:<br>Combining HBG’s healthcare insight with Atumcell’s cybersecurity expertise, we assessed insurer requirements, benchmarked peer initiatives, and interviewed brokers, carriers, CIOs, and vendors. We outlined service models including education, pooled purchasing, and a statewide Security Operations Center (SOC) and prepared a CEO-level presentation to guide board decisions.<br><br>Impact:<br>The engagement produced a comprehensive strategy for a statewide cybersecurity initiative. The plan aligned technical leaders and CEOs, laying the groundwork for a sustainable new line of business.<br><br>Why It Matters:<br>Cyber risk is now a board-level issue. HBG helps healthcare leaders design solutions that satisfy insurers, regulators, and front-line operators alike.</p><p class="">Thumbnail Summary: Amid soaring ransomware losses, a state hospital association engaged HBG and Atumcell to craft a collaborative cybersecurity strategy to reduce insurance risk and created a sustainable new service line.</p><p class="">SEO Meta Description: HBG and Atumcell designed a cybersecurity strategy to improve insurance resilience for hospital networks.</p>]]></content:encoded></item><item><title>Molecular Diagnostics: Making the Right Technology Choice</title><dc:creator>Li Wang</dc:creator><pubDate>Sun, 14 Dec 2025 14:10:45 +0000</pubDate><link>https://www.healthbusinessgroup.com/ai-case-studies-growth/molecular-diagnostics-making-the-right-technology-choice</link><guid isPermaLink="false">6238b65ed9ed4068c58aff9b:693ec51b74ef1043669c1bfc:693ec556fb3a1757f05302fc</guid><description><![CDATA[A breakthrough technology promised faster, simpler disease-activity testing 
but clashed with the firm’s original complex platform. Board, founder, and 
management were deadlocked over which path to pursue.]]></description><content:encoded><![CDATA[<p class="">Client Type: Development-stage diagnostics company<br><br>Challenge:<br>A breakthrough technology promised faster, simpler disease-activity testing but clashed with the firm’s original complex platform. Board, founder, and management were deadlocked over which path to pursue.<br><br>Approach:<br>HBG conducted a full portfolio assessment—market sizing, regulatory timelines, payer and provider adoption potential, and cost comparisons. We interviewed KOLs and board members, synthesized findings, and facilitated a strategy offsite to structure choices and build consensus.<br><br>Impact:<br>The process clarified tradeoffs and enabled board and management agreement on a single technology direction. The company moved forward with a shared vision and implementation roadmap.<br><br>Why It Matters:<br>Scientific innovation can fracture leadership alignment. HBG combines analytic rigor and facilitation skill to help boards make decisive choices.</p><p class="">Thumbnail Summary: HBG helped a diagnostics company navigate board conflict over competing technologies, facilitating data-driven decisions that unified stakeholders and clarified the company’s growth strategy.</p><p class="">SEO Meta Description: HBG helped a diagnostics company align leadership on a single technology path for faster growth.</p>]]></content:encoded></item></channel></rss>